custom image

Precision Engineering of the Genome, Epigenome and Transcriptome

March 8-10, 2021 | 10:00AM EST | 3:00PM UTC | 4:00PM CET*
*Program is in development and subject to change


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.

 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries

Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.

Apply Here

Over the last several years, new genome engineering tools have revolutionized the ability to interrogate biological systems, engineer innovative biotechnologies, and model and treat human disease. The genome engineering field continues to evolve at a frenzied pace, including both the development of new fundamental tools and their application to addressing societal needs. This Keystone Symposium will cover this spectrum of advances, including the most recent technological innovations in genome, epigenome, and transcriptome precision engineering. The conference will also highlight recent advances in developing human therapeutics with these tools, including emerging clinical trial results and preclinical examples of novel modes of intervention. The Symposium will include a variety of topics of interest to the broad research community, including next-generation applications such as high-throughput screening, synthetic biology, and chromatin and RNA imaging and diagnostics. Finally, the Symposium will conclude with examples of how emerging technologies can be integrated for an unprecedented level of resolution of cellular processes – such as genome engineering combined with single-cell analysis methods. Collectively, this meeting will build on its history of success by familiarizing the audience with the latest advances in tool development, providing an update on clinical application of these tools, and generating an appreciation for the breadth of scientific areas impacted by the Genome Engineering Revolution.

Apply Here for Free On Demand Access


Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD


Abstract Submission:
‣ For Short Talk Consideration: February 2, 2021
‣ For Poster Booth: February 22, 2021
ePoster / SciTalk Submission: February 25, 2021
Financial Aid Application: February 22, 2021

*Please note, abstract submission is required
in order to submit an ePoster and/or Scitalk


Financial Aid Opportunities

Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine related fields, are eligible to apply for a FREE registration code.

Find out more about financial aid opportunities here!

Call For Abstracts

Showcase your work to global audiences on the eSymposia platform!

Submit your abstract for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program! See Abstract Deadline for Short Talk Consideration

ePoster presenters will be provided with their own dedicated page on the event website to display their work in multiple formats and interact with meeting participants. ePoster features include:

  • Abstract
  • Poster PDF for download
  • SciTalk – up to 5 minute video presentation, available on-demand
  • Live chat function to answer audience questions in real-time
  • Contact information for private follow-up discussion

To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.

Program Details

Speaking at this eSymposia

Britt S. Adamson

Princeton University, USA

Aravind Asokan

Duke University, USA

Chiara Bonini

Ospedale San Raffaele, Italy

Jacob E. Corn

ETH Zürich, Switzerland

Cecilia Cotta-Ramusino

Tessera Therapeutics, USA

James Dahlman

Georgia Tech / Emory Medical School, USA

John G. Doench

Broad Institute of MIT and Harvard University, USA

Nicole Gaudelli

Beam Therapeutics, USA

Charles Gersbach

Duke University, USA

Rachel E. Haurwitz

Caribou Biosciences Inc., USA

Patrick D. Hsu

University of California, Berkeley, USA

Ahmad S. Khalil

Boston University, USA

Hyongbum Henry Kim

Yonsei University College of Medicine, South Korea

Prashant Mali

University of California, San Diego, USA

Jennifer E. Phillips-Cremins

University of Pennsylvania, USA

Samuel H. Sternberg

Columbia University, USA

Fyodor D. Urnov

University of California, Berkeley, USA

Bas van Steensel

Netherlands Cancer Institute, Netherlands

Jonathan S. Weissman

Whitehead Institute and MIT, USA

Kathryn Whitehead

Carnegie Mellon University, USA

Tim W. Yu

Boston Children's Hospital, USA

More program details will be available soon.

Subscribe to receive updates to the program for this meeting.

Email address:    





Additional Support





Funding for this conference was made possible (in part) by Grant No. [GRANT NUMBER - UPDATE] from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Media-in-Kind Support









This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.

The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.

Related Keystone Symposia In-Person Meetings

Explore all cancer-related meetings on the Keystone Symposia website.

custom image

custom image

custom image

Donate to Keystone Symposia

custom image